These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15194033)

  • 21. Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury.
    Mulukutla SR; Marroquin OC; Smith C; Varghese R; Anderson WD; Lee JS; Cohen HA; Counihan PJ; Lee AB; Gulati V; McNamara D
    Am J Cardiol; 2004 Dec; 94(11):1363-6. PubMed ID: 15566904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advantage of percutaneous coronary intervention over medical therapy in angina relief and the placebo effect.
    Rott D
    J Am Coll Cardiol; 2005 Jan; 45(2):327-8; author reply 328. PubMed ID: 15653043
    [No Abstract]   [Full Text] [Related]  

  • 24. Action profiles of statins and calcineurin inhibitors during human mixed lymphocyte reaction.
    Takahashi HK; Iwagaki H; Yagi T; Kanke T; Liu K; Yoshino T; Tanaka N; Nishibori M
    Clin Immunol; 2007 Jun; 123(3):324-32. PubMed ID: 17482516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes.
    Han SF; Liu P; Zhang W; Bu L; Shen M; Li H; Fan YH; Cheng K; Cheng HX; Li CX; Jia GL
    Clin Immunol; 2007 Jul; 124(1):90-7. PubMed ID: 17512253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
    Patti G; Chello M; Pasceri V; Colonna D; Nusca A; Miglionico M; D'Ambrosio A; Covino E; Di Sciascio G
    J Am Coll Cardiol; 2006 Oct; 48(8):1560-6. PubMed ID: 17045888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
    Czyz A; Kołacz E; Angerer D; Zawilska K
    Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous coronary interventions and statins therapy.
    Nusca A; Melfi R; Di Sciascio G
    Ther Adv Cardiovasc Dis; 2008 Apr; 2(2):101-7. PubMed ID: 19124413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation between CD4+ T-cell activation and severity of chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Fukunaga T; Soejima H; Irie A; Sugamura K; Oe Y; Tanaka T; Nagayoshi Y; Kaikita K; Sugiyama S; Yoshimura M; Nishimura Y; Ogawa H
    Am J Cardiol; 2007 Aug; 100(3):483-8. PubMed ID: 17659933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization.
    Breeman A; Hordijk-Trion M; Lenzen M; Hoeks S; Ottervanger JP; Bertrand ME; Sechtem U; Zaliunas R; Legrand V; de Boer MJ; Stahle E; Mercado N; Wijns W; Boersma E;
    J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1001-9. PubMed ID: 17059915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recapturing the magic: revisiting the pleiotropic effects of statins in percutaneous coronary revascularization.
    Ellis SG; Anwaruddin S
    J Am Coll Cardiol; 2009 Aug; 54(6):566-8. PubMed ID: 19643321
    [No Abstract]   [Full Text] [Related]  

  • 32. Statins induce immunosuppressive effect on heterotopic limb allografts in rat through inhibiting T cell activation and proliferation.
    Nie C; Yang D; Liu G; Dong D; Ma Z; Fu H; Zhao Z; Sun Z
    Eur J Pharmacol; 2009 Jan; 602(1):168-75. PubMed ID: 19041862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
    Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris.
    Inami N; Nomura S; Manabe K; Kimura Y; Iwasaka T
    Platelets; 2006 Dec; 17(8):565-70. PubMed ID: 17127484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical therapy versus percutaneous coronary intervention for patients with stable coronary artery disease.
    Arbab-Zadeh A
    J Am Coll Cardiol; 2009 Feb; 53(6):528-9; author reply 529. PubMed ID: 19195616
    [No Abstract]   [Full Text] [Related]  

  • 36. Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes.
    Methe H; Brunner S; Wiegand D; Nabauer M; Koglin J; Edelman ER
    J Am Coll Cardiol; 2005 Jun; 45(12):1939-45. PubMed ID: 15963390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions.
    Khanal S; Attallah N; Smith DE; Kline-Rogers E; Share D; O'Donnell MJ; Moscucci M
    Am J Med; 2005 Aug; 118(8):843-9. PubMed ID: 16084176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention.
    Wolfram RM; Torguson RL; Hassani SE; Xue Z; Gevorkian N; Pichard AD; Satler LF; Kent KM; Waksman R
    Am J Cardiol; 2006 Apr; 97(7):984-9. PubMed ID: 16563901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restenosis after successful ostial stent implantation: the role of statins compared with conventional treatment.
    Horlitz M; Amin FR; Boerrigter G; Sigwart U; Clague JR
    J Interv Cardiol; 2004 Oct; 17(5):301-6. PubMed ID: 15491333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term (11-year) statin therapy following percutaneous coronary intervention improves clinical outcome and is not associated with increased malignancy.
    Kasai T; Miyauchi K; Kurata T; Satoh H; Ohta H; Tanimoto K; Kawamura M; Okazaki S; Yokoyama K; Kojima T; Akimoto Y; Daida H
    Int J Cardiol; 2007 Jan; 114(2):210-7. PubMed ID: 16797744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.